Skip to main content
. Author manuscript; available in PMC: 2024 Aug 29.
Published in final edited form as: Biochem Pharmacol. 2021 Sep 21;193:114781. doi: 10.1016/j.bcp.2021.114781

Fig. 9. Signalling characteristics exhibited by the ZACL9′X mutants.

Fig. 9.

A. Representative traces of currents evoked by saturating Zn2+ concentrations in WT ZAC-, ZACL9′A-, ZACL9′V-, ZACL9′I- and ZACL9′T-expressing oocytes. 10 mM Zn2+ was used for WT ZAC and 1 mM Zn2+ was used for the ZACL9′X mutants, respectively. B. Representative traces of currents evoked by sustained application of saturating Zn2+ concentrations in WT ZAC- and ZACL9′I-expressing oocytes. 10 mM Zn2+ and 1 mM Zn2+ were used for WT ZAC and for ZACL9′I, respectively.